🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our CEO, Luca Emili, and Head of AI, Marco Virgolin, PhD, will be attending the the AI Summit 2025 in London on June 11–12. 𝗔𝗜 𝗶𝘀 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗲𝘃𝗲𝗿𝘆 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 — 𝗮𝗻𝗱 𝘄𝗲’𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗯𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗮𝘁

𝗪𝗵𝗮𝘁 𝗶𝗳 𝗶𝗻 𝘀𝗶𝗹𝗶𝗰𝗼 𝗺𝗲𝘁𝗵𝗼𝗱𝘀 𝗰𝗼𝘂𝗹𝗱 𝗵𝗲𝗹𝗽 𝘂𝘀 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝘁𝗵𝗲 𝗶𝗻𝘃𝗶𝘀𝗶𝗯𝗹𝗲? Today is 𝗪𝗼𝗿𝗹𝗱 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 𝗗𝗮𝘆, and we remember that MS doesn’t just challenge the body—it challenges science. It’s complex,

The BRAINTEASER Project Final Event, held this week at 𝗘𝗡𝗖𝗔𝗟𝗦 in Turin, was a great success, with a full room of engaged attendees! As partners of the BRAINTEASER Project, InSilicoTrials was represented by our Senior R&I Project Manager, Vincenzo Carbone, who

𝗥𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲 — 𝗔𝗦𝗖𝗢 𝟮𝟬𝟮𝟱 Last week in Chicago, our colleagues Sofia Stathopoulos, VP of Business Development, and Simona Catozzi, Research Scientist, joined thousands of oncology professionals from around the world at the ASCO Annual

𝗠𝗲𝗲𝘁 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗔𝗜 𝗦𝘂𝗺𝗺𝗶𝘁 𝗟𝗼𝗻𝗱𝗼𝗻, 𝗼𝗽𝗲𝗻𝗶𝗻𝗴 𝗶𝗻 𝗷𝘂𝘀𝘁 𝟭 𝗱𝗮𝘆! AI is no longer a future concept, it’s a tool we’re using today to rethink how research and development gets done. 𝗙𝗿𝗼𝗺 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝘁𝘄𝗶𝗻𝘀 𝘁𝗼 𝘃𝗶𝗿𝘁𝘂𝗮𝗹

𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗮𝗿𝗲 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗔𝗜 𝗶𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗰𝗲𝗻𝘁𝗲𝗿 𝗼𝗳 𝘁𝗵𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻. Meet us June 18-19 at HealthIMPACTLIVE, hosted at Microsoft's NYC offices in Times Square, and discover how we're helping shape the future

InSilicoTrials 𝗷𝗼𝗶𝗻𝘀 𝘁𝗵𝗲 Microsoft for Startups 𝗣𝗲𝗴𝗮𝘀𝘂𝘀 𝗣𝗿𝗼𝗴𝗿𝗮𝗺, 𝗮𝗻𝗱 𝗳𝗼𝗿 𝘂𝘀, 𝘁𝗵𝗶𝘀 𝗶𝘀 𝗮 𝗽𝗼𝘄𝗲𝗿𝗳𝘂𝗹 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻. When we started, our goal was clear: 𝗯𝗿𝗶𝗻𝗴 𝗰𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝘀𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗔𝗜 𝘁𝗼

Next week, June 16-19, our team CEO Luca Emili, COO mario torchia, and VP of Business Development Sofia Stathopoulos will be at the BIO International Convention 2025. It promises to be a week full of networking, meetings, and meaningful conversations at one of the most

𝗘𝗔𝗖𝗣𝗧 𝟮𝟬𝟮𝟱, 𝗛𝗲𝗹𝘀𝗶𝗻𝗸𝗶, 𝗙𝗶𝗻𝗹𝗮𝗻𝗱 | 𝟮𝟴 𝗝𝘂𝗻𝗲 - 𝟭 𝗝𝘂𝗹𝘆 The 𝗘𝗔𝗖𝗣𝗧 𝟮𝟬𝟮𝟱 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 is just around the corner, bringing together global leaders in clinical pharmacology to exchange insights that shape the future of patient care. Maud

𝗙𝗼𝘂𝗿 𝗱𝗮𝘆𝘀 𝗮𝘁 𝗕𝗜𝗢 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝟮𝟬𝟮𝟱! BIO International Convention 2025 in Boston is ending today, and what a remarkable gathering of innovation, vision, and opportunity it has been. InSilicoTrials was proud to be part of this

InSilicoTrials 𝗻𝗮𝗺𝗲𝗱 𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗳𝗮𝘀𝘁𝗲𝘀𝘁-𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝗯𝘆 𝗦𝗶𝗳𝘁𝗲𝗱 We’re proud to be featured in the 𝗦𝗶𝗳𝘁𝗲𝗱 𝟭𝟬𝟬 – France & Southern Europe 2025, a list that highlights the most promising and fastest-growing startups, based on

𝗠𝗲𝗲𝘁 InSilicoTrials 𝗮𝘁 𝗘𝗔𝗖𝗣𝗧 𝟮𝟬𝟮𝟱! From June 28 to July 1, Maud Beneton, our Director of Clinical Pharmacology, will be on the ground in Helsinki for EACPT 𝟮𝟬𝟮𝟱, a key meeting where Europe's pharmacology community comes together. She'll be presenting a

𝗪𝗲’𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝘁𝗵𝗮𝘁 𝗼𝘂𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘄𝗶𝘁𝗵 Luigi Rovito, 𝗣𝗼𝘀𝘁-𝗗𝗼𝗰 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿 𝗮𝘁 𝘁𝗵𝗲 Università degli Studi di Trieste (Università di Trieste), 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗮𝗰𝗰𝗲𝗽𝘁𝗲𝗱 𝗮𝘁 GECCO 2025 𝟮𝟬𝟮𝟱.

𝗖𝗮𝗻 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝘁𝗿𝘂𝗹𝘆 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗵𝗼𝘄 𝘄𝗲 𝗳𝗶𝗴𝗵𝘁 𝗰𝗮𝗻𝗰𝗲𝗿? Next week, our VP of Business Development, Sofia Stathopoulos, will be in Montreal for the AACR 𝗦𝗽𝗲𝗰𝗶𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗶𝗻 𝗖𝗮𝗻𝗰𝗲𝗿

Join our CEO Luca Emili on 𝗝𝘂𝗹𝘆 𝟭𝟬 𝟭𝟱:𝟰𝟬-𝟭𝟲:𝟮𝟬 𝗖𝗘𝗦𝗧 as he takes the virtual stage at a webinar hosted by AICRO, the Italian Association of Contract Research Organizations. His session, “𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗩𝗮𝗹𝘂𝗲 𝗼𝗳

𝗗𝗘𝗠𝟭𝟬 𝗥𝗲𝗰𝗮𝗽 𝗳𝗿𝗼𝗺 𝗛𝗶𝗺𝗲𝗷𝗶 From particle modeling to AI-driven simulation, 𝗗𝗘𝗠𝟭𝟬 in Himeji, Japan brought together the brightest minds in particulate systems. Alongside our partner RCPE, InSilicoTrials was proud to support this important event and help

𝗢𝘂𝗿 𝗪𝗶𝗻 𝗮𝘁 𝘁𝗵𝗲 𝗔𝗜 𝗦𝘂𝗺𝗺𝗶𝘁 𝗟𝗼𝗻𝗱𝗼𝗻 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗶𝗻 𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿 𝗨𝗞! Entrepreneur UK covered our win in the pitching competition at 𝗧𝗵𝗲 𝗔𝗜 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱, spotlighting why InSilicoTrials stood out in one of Europe’s most

Montreal’s AACR 𝗦𝗽𝗲𝗰𝗶𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗶𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: 𝗔𝗜 𝗮𝗻𝗱 𝗠𝗮𝗰𝗵𝗶𝗻𝗲 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 has kicked off, with our VP of Business Development, Sofia Stathopoulos, taking part. From advanced simulations to innovative AI applications,

In healthcare and drug development, synthetic data is gaining traction, but the term is being used in vastly different ways. We just published a new blog post exploring this very question, alongside our supporting paper: "𝗦𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗗𝗮𝘁𝗮 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲

𝗪𝗼𝗿𝗹𝗱 𝗔𝗜 𝗗𝗮𝘆, 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗥𝗶𝘀𝗲 𝗼𝗳 𝗦𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗗𝗮𝘁𝗮 Innovating with AI in healthcare and drug development comes with responsibility. At InSilicoTrials, we prioritize responsible AI practices to ensure our models are